4-甲基-2-(4-甲基哌嗪-1-基)喹啉 | 100949-89-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 4-甲基-2-(4-甲基哌嗪-1-基)喹啉
• 英文名称: 4-methyl-2-(4-methylpiperazin-1-yl)quinoline
• 英文别名: 4-methyl-2-(4-methyl-piperazino)-quinoline；4-Methyl-2-(4-methyl-piperazino)-chinolin；1-(4-methyl-2-quinolinyl)-4-methylpiperazine
• CAS: 100949-89-1
• 化学式: C₁₅H₁₉N₃
• mdl: MFCD00817928
• 分子量: 241.336
• InChiKey: FRJPYTKAMYVLFY-UHFFFAOYSA-N

物化性质

• 熔点：
  55-57 °C
• 沸点：
  410.5±45.0 °C(Predicted)
• 密度：
  1.115±0.06 g/cm3(Predicted)
• 溶解度：
  32.9 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  19.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-甲基-2-(4-甲基哌嗪-1-基)喹啉 在 palladium on activated charcoal 氢气 、 硝酸 作用下， 以 四氢呋喃 为溶剂， 反应 25.0h， 生成 4-methyl-2-(4-methylpiperazin-1-yl)quinolin-6-ylamine
  参考文献：
  名称：

  6-Acylamino-2-aminoquinolines as Potent Melanin-Concentrating Hormone 1 Receptor Antagonists. Identification, Structure−Activity Relationship, and Investigation of Binding Mode

  摘要：

  Novel 6-acylamino-2-aminoquinoline melanin-concentrating hormone 1 receptor (MCHIR) antagonists were identified by sequential in silico screening with 3D pharmacophore models derived from a series of benzamide antagonists. The structure- activity relationship exploration by synthesis of analogues found structural demands around the western part of the compounds to be quite specific, whereas much structural freedom was found in the eastern part. Vvhile these compounds in general suffered from poor solubility properties, the 4-trifluoromethoxy-phenoxyacetamide western appendage provided a favorable combination of activity and solubility properties. The amine in the eastern appendage, originally required by the pharmacophore model and believed to interact with Asp123 in transmembrane 3 of MCH1R, could be removed without diminishing affinity or functional activity of the compounds. Docking studies suggested that the Asp123 interacts preferentially with the nitrogen of the central quinoline. Synthesis and testing of specific analogues supported our revised binding mode hypothesis.

  DOI：

  10.1021/jm050103y
• 作为产物：
  描述：

  N-甲基哌嗪 、 4-甲基-2-氯-喹啉 反应 16.0h， 以98%的产率得到4-甲基-2-(4-甲基哌嗪-1-基)喹啉
  参考文献：
  名称：

  6-Acylamino-2-aminoquinolines as Potent Melanin-Concentrating Hormone 1 Receptor Antagonists. Identification, Structure−Activity Relationship, and Investigation of Binding Mode

  摘要：

  Novel 6-acylamino-2-aminoquinoline melanin-concentrating hormone 1 receptor (MCHIR) antagonists were identified by sequential in silico screening with 3D pharmacophore models derived from a series of benzamide antagonists. The structure- activity relationship exploration by synthesis of analogues found structural demands around the western part of the compounds to be quite specific, whereas much structural freedom was found in the eastern part. Vvhile these compounds in general suffered from poor solubility properties, the 4-trifluoromethoxy-phenoxyacetamide western appendage provided a favorable combination of activity and solubility properties. The amine in the eastern appendage, originally required by the pharmacophore model and believed to interact with Asp123 in transmembrane 3 of MCH1R, could be removed without diminishing affinity or functional activity of the compounds. Docking studies suggested that the Asp123 interacts preferentially with the nitrogen of the central quinoline. Synthesis and testing of specific analogues supported our revised binding mode hypothesis.

  DOI：

  10.1021/jm050103y

文献信息

• Quinoline compounds for use in mch receptor related disorders
  申请人：Frimurer Michael Thomas

  公开号：US20060111357A1

  公开（公告）日：2006-05-25

  The present invention relates to the use of quinoline compounds for the preparation of a pharmaceutical and/or a cosmetic composition for the treatment, prophylaxis and/or diagnosis of a condition caused by or involving a melanin-concentrating hormone. The invention also relates to novel quinoline compounds per se. The quinoline compounds have been found to interact with a melanin-concentrating hormone receptor, a MCH receptor. The compounds have modulating activity on the MCH receptor such as e.g. antagonistic, agonistic or allosteric activity and are useful for medicinal or cosmetic purposes such as, e.g. in the treatment or prevention of feeding disorders like obesity, metabolic syndrome, Type II diabetes, bulimia, etc. or in the treatment or prevention of depression.

  本发明涉及使用喹啉化合物制备用于治疗、预防和/或诊断由或涉及黑色素浓缩激素引起的疾病的药物和/或化妆品组合物。本发明还涉及新型喹啉化合物本身。已发现喹啉化合物与黑色素浓缩激素受体（MCH受体）相互作用。该化合物对MCH受体具有调节活性，例如拮抗、激动或异构活性，并可用于药用或化妆品用途，例如治疗或预防饮食障碍，如肥胖症、代谢综合征、2型糖尿病、贪食症等，或治疗或预防抑郁症。
• Amino substituted benzo(hetero)cyclic derivatives
  申请人：Steiner Gerd

  公开号：US20060166984A1

  公开（公告）日：2006-07-27

  Use of compounds Formula (I), A=a 5- to 7-membered ring which may contain 1-3 heteroatoms and which may be saturated or partially or completely unsaturated; R 1 ═OH, SH, NH 2 , CN, NO 2 , halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl; C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 2 -C 6 -alkenyl, C 2 -C 6 alkenyloxy, C 2 -C 6 -alkenylthio, C 2 -C 6 -alkynyl, C 2 -C 6 -alkynyloxy, C 2 -C 6 -alkynylthio, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -alkylsulfoxyl, C 2 -C 6 -alkenylsulfonyl, C 2 -C 6 -alkylsulfoxyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -aklylcarbonyloxy; R 2 ═C 1 -C 6 -alkyl or a mono- or bicyclic 5- to 10-membered aromatic ringsystem which may contain 1 to 4 heteroatoms and which is either bonded directly or through an O, S, C 1 -C 6 -alkylene or C 1 -C 6 -alkyleneoxy linkage to A or fused to A and which may be substituted; R 3 , R 4 ═H, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkyl-amino, C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, or R 3 and R 4 together with the nitrogen atom to which they are attached form a saturated or partially saturated mono- or bicyclic 5- to 10-membered ring system containing 1 to 3 heteroatoms or a 5-membered hetaryl containing 1 to 4 nitrogen atoms, wherein the carbon and/or nitrogen atoms in the ring systems may be substituted or phenyl or benzyl which may be substituted; or R 3 and R 4 together form the chains —(CH 2 ) 2 N + (O—)(CH 2 ) 2 — or —(CH 2 ) 3 N + (O − )(CH 2 ) 2 —; m=0 to 4; n is 0 to 4; and the enantiomers, diastereomers, cis/trans isomers or salts thereof for combatting insects, arachnids or nematodes, methods for the control of these pests and of protecting growing plants attack or infestation by these pests by applying a pesticidally effective amount of a compound of formula (I), processes for preparing them, and compositions comprising them.

  化合物公式（I）的使用，其中A=a 5-至7-成员环，可能包含1-3个杂原子，并且可能是饱和的或部分或完全不饱和的；R1═OH、SH、NH2、CN、NO2、卤素、C1-C6-烷基、C1-C6-卤代烷基；C1-C6-烷氧基、C1-C6-卤代烷氧基、C1-C6-烷硫基、C1-C6-卤代烷硫基、C2-C6-烯基、C2-C6-烯氧基、C2-C6-烯硫基、C2-C6-炔基、C2-C6-炔氧基、C2-C6-炔硫基、C1-C6-烷基磺酰基、C1-C6-烷基亚砜基、C2-C6-烯基磺酰基、C2-C6-烷基亚砜基、C1-C6-烷基羰基、C1-C6-烷氧基羰基、C1-C6-烷基羰氧基；R2═C1-C6-烷基或单环或双环5-至10-成员芳香环系统，可能包含1至4个杂原子，直接或通过O、S、C1-C6-烷基或C1-C6-烷氧基连接到A或融合到A上，并且可能被取代；R3、R4═H、C1-C6-烷基、C1-C6-卤代烷基、C1-C6-烷基氨基、C1-C6-烷氧基、C3-C6-环烷基，或R3和R4与它们连接的氮原子一起形成一个饱和或部分饱和的单环或双环5-至10-成员环系统，其中包含1至3个杂原子或一个含1至4个氮原子的5-成员杂芳基，环系统中的碳和/或氮原子可能被取代，或苯基或苄基，可以被取代；或R3和R4一起形成链-（CH2）2N+（O-）（CH2）2-或-（CH2）3N+（O-）（CH2）2-；m=0至4；n为0至4；其对抗昆虫、蜘蛛或线虫的恶性化合物的对映体、非对映异构体、顺反异构体或其盐，以及通过施用公式（I）的杀虫剂有效量来控制这些害虫和保护生长中的植物免受这些害虫的攻击或侵染的方法，制备它们的方法以及包含它们的组合物。
• Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists
  作者：Rosa Arienzo、David E Clark、Sue Cramp、Stephen Daly、Hazel J Dyke、Peter Lockey、Dennis Norman、Alan G Roach、Keith Stuttle、Maxine Tomlinson、Melanie Wong、Stephen P Wren

  DOI：10.1016/j.bmcl.2004.05.051

  日期：2004.8

  A new series of 2-aminoquinolines has been identified as antagonists of the melanin concentrating hormone receptor (MCH-1R). Syntheses and structure-activity relationships are described leading to a compound having low nanomolar activity against the receptor and demonstrating functional antagonism. Studies also showed that some of the compounds were selective against a range of other G protein-coupled receptors. (C) 2004 Elsevier Ltd. All rights reserved.
• UNSYMMETRICALLY DISUBSTITUTED PIPERAZINES. II. HISTAMINE ANTAGONISTS¹
  作者：LEWIS P. ALBRO、RICHARD BALTZLY、ARTHUR P. PHILLIPS

  DOI：10.1021/jo01157a008

  日期：1949.9
• QUINOLINE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS
  申请人：7TM Pharma A/S

  公开号：EP1572212A2

  公开（公告）日：2005-09-14